Disposal-Amendment

RNS Number:2024K
Healthcare Enterprise Group PLC
18 December 2007



THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE
UNITED STATES, CANADA, JAPAN, AUSTRALIA OR SOUTH AFRICA


18 December 2007


This announcement replaces RNS announcement 8208J released on 13 December 2007
at 8.47am.  Cancer Therapeutics, Inc. was formerly a biotherapy company but is
now a non-operating shell.


Healthcare Enterprise Group PLC


Disposal of Ridgecrest Healthcare holding.


Healthcare Enterprise Group plc (AIM: HCEG, "HCEG", the "Group", the "Company"),
the international healthcare products group has sold its minority shareholding
in Ridgecrest Healthcare Group Inc. ("Ridgecrest"), the US pink sheets listed
healthcare consulting and advisory group.

The consideration is being satisfied by way of exchange for 1,125,000 shares in
ValiRx plc, the AIM listed therapeutic research and development company (AIM:
VAL), plus an additional 300,000 shares in ValiRx, once filing of a patent
application with the UK Patent Office in relation to certain intellectual
property arrangements has been made.

HCEG will also receive 400,000 shares and 700,000 warrants in the US-based
Cancer Therapeutics, Inc., a former biotherapy company that is now a
non-operating shell.

This exchange of assets is not expected to result in any material change to the
carrying value of the Group's investment in Ridgecrest which was £510,000 on 28
February 2007.  The Board plans to realise these investments in an orderly
manner at the earliest opportunity.

Lyndon Gaborit, Executive Deputy Chairman, said:

"We are pleased to complete our first disposal into a more readily realisable
and liquid investments.  Cash proceeds from disposals will be used to reduce
further the Group's borrowing and provide additional working capital for its
operations."

Enquiries:

Healthcare Enterprise Group PLC                     01925 898 200
Lyndon Gaborit, Executive Deputy Chairman

Numis                                               020 7260 1000
David Poutney

College Hill                                        020 7457 2020
Adrian Duffield / Jon Davies



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

DISGUGACPUPMGAR